Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong · Delayed Price · Currency is HKD 13.04
-0.12 (-0.91%)
Sep 11, 2026, 4:08 PM HKT
HKG:1681 Revenue
Consun Pharmaceutical Group had revenue of 1.78B CNY in the half year ending June 30, 2026, with 40.69% growth. This brings the company's revenue in the last twelve months to 3.63B, up 11.21% year-over-year. In the year 2025, Consun Pharmaceutical Group had annual revenue of 3.42B with 15.17% growth.
Revenue (ttm)
3.63B CNY
Revenue Growth
+11.21%
P/S Ratio
2.63
Revenue / Employee
1.28M CNY
Employees
2,847
Market Cap
11.04B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.42B | 450.12M | 15.17% |
| Dec 31, 2024 | 2.97B | 377.12M | 14.56% |
| Dec 31, 2023 | 2.59B | 250.47M | 10.71% |
| Dec 31, 2022 | 2.34B | 294.99M | 14.43% |
| Dec 31, 2021 | 2.04B | 291.83M | 16.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 14.68B |
| The United Laboratories International Holdings | 13.69B |
| Grand Pharmaceutical Group | 12.48B |
| Shandong Xinhua Pharmaceutical Company | 9.78B |
| Luye Pharma Group | 7.08B |
| SSY Group | 4.38B |
| Sihuan Pharmaceutical Holdings Group | 3.04B |
| CanSino Biologics | 1.43B |
Consun Pharmaceutical Group News
- 16 days ago - Consun Pharmaceutical Group Earnings release: H1 2026 - Filings